Evolving Landscape of Glioma: A Focus on IDH-Mutant Gliomas
Vinay K. Puduvalli, MD, explores recent advances in glioma classification and treatment, discussing the impact of new WHO guidelines, molecular markers, clinical trials, and emerging therapies like IDH inhibitors on patient care strategies, while identifying persisting challenges and future research priorities in neuro-oncology.
EP. 1: Real-World Clinical Practice: Challenges With Glioma Management
November 4th 2024Panelists discuss how the updated WHO classification system for gliomas has impacted their treatment approaches, while also addressing the practical difficulties of integrating these changes into routine clinical care.
EP. 2: Treatment Approaches for Patients With Oligodendrogliomas and Grade 2 Gliomas
November 11th 2024Panelists discuss how they tailor treatment strategies for oligodendrogliomas and Grade 2 gliomas based on key clinical and molecular markers, with particular attention to insights from the CODEL trial and RTOG 9802 study.
